Loss of appetite or stopping eating entirely is common among patients with late-stage Alzheimer’s. Why does it happen, and what can caregivers do? A…
Cuba has quietly been developing their own Alzheimer’s treatment. It’s administered nasally. And it’s just entered clinical trials. The United States imposed a blockade…
AmyriAD Therapeutics CEO Sharon L. Rogers shares the scoop on AmyriAD’s investigational Alzheimer’s drug AD101. The majority of experimental Alzheimer’s drugs are being designed…
Drugmaker Eli Lilly says experimental Alzheimer’s drug remternetug is part of the next generation of anti-amyloids. The approval of the controversial anti-amyloid drug Aduhelm…
Alzheimer’s and dementia experts tackle reader questions on Alzheimer’s sundowning symptoms. What stage of Alzheimer’s is sundowning? What are the early signs, how long…
Could insulin treat Alzheimer’s the same way it treats diabetes? Evidence shows Alzheimer’s might be more similar to a metabolic disorder, like diabetes, than…
Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD, showing the drug is as safe as the placebo with improvements…